CRNX

$84.44-$0.02 (-0.02%)prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Market cap

$9.0B

106M shares

52-week range

$28.73 – $84.71

100% from low

Sector

PHARMACEUTICAL PREPARATIONS

Exchange

NASDAQ

Change+$61.34

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$69M	+983.8%	$-4.66	$-5.07–$-3.97	—	11
2027	$172M	+151.0%	$-4.05	$-4.58–$-3.30	—	10
2028	$418M	+142.8%	$-2.23	$-3.27–$-0.68	—	6
2029	$916M	+119.2%	$0.98	$0.68–$1.33	86.5×	3

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 3 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-03	$-1.18	$-1.14	+3.4%
2026-05-07	$-1.22	$-1.23	-0.8%
2026-02-26	$-1.37	$-1.29	+5.8%
2025-11-06	$-1.27	$-1.38	-8.7%
2025-08-07	$-1.13	$-1.23	-8.8%
2025-05-08	$-0.99	$-1.04	-5.1%
2025-02-27	$-0.92	$-0.88	+4.3%
2024-11-12	$-0.91

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CRNXCrinetics Pharmaceuticals, Inc.	$84.44	-0.02%	$8.9B	—
ACADACADIA Pharmaceuticals Inc.	$28.44	-3.43%	$4.9B	—
AKROAkero Therapeutics, Inc.	$54.65	+0.00%	$4.5B	—
DYNDyne Therapeutics, Inc.	$25.95	-0.84%	$4.8B	—
IMVTImmunovant, Inc.	$41.77	-1.95%

Crinetics Pharmaceuticals, Inc.

Crinetics Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its main product, Palsonify (paltusotine), is a once-daily, oral treatment approved by the FDA for adults with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option. Additionally, the company's development pipeline includes several programs, including a late-stage investigational candidate, atumelnant, currently in development for CAH and ADCS, and CRN09682, a NDC candidate that is being developed to treat SST2-expressing NETs and other SST2-expressing solid tumors.

www.crinetics.com

Employees: 594
IPO / List date: Jul 18, 2018
HQ: SAN DIEGO, CA

Held by traders on TradeandTell

No one on the platform currently holds CRNX.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CRNX as of their last filing.

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded CRNX yet.

$CRNX chatter on StockTwits

Stock Analysis@stockanalysis_5d
RSI above 70: these are the most stretched stocks on the daily chart. $CRNG $RACC $MAGH $CRNX $SMJF See the complete daily-updated overbought list: https://stockanalysis.com/list/overbought-stocks/?ref=saveontrading
View on StockTwits ↗
Mergerbrief.com@Mergerbrief6d
$CRNX / $VRTX – Germany Possible Expire
View on StockTwits ↗
Stocktwits Earnings@StocktwitsEarningsAug 3
$CRNX Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$1.14 up 7.32% YoY • Reported revenue of $25.12M up 2336.28% YoY
View on StockTwits ↗
The Stock Navigator@StockNavigator_Jul 24
Two months ago, I shared this watchlist with you… This month’s focus: $INHD +3000%+ $VEEE +400%~450% $SOBR +around 100% $WBUY +70%~80% $CRNX +50%~60% Not every setup will play out the same way, but the biggest opportunities often come from names that are still being overlooked. Stay focused. Stay patient. If you want to see the high-conviction stocks I’m watching, my full portfolio, and every trade I make… Head to my profile.
View on StockTwits ↗
The Stock Navigator@StockNavigator_Jul 23
This month, I’m watching… 5 stocks with strong potential heading into 2027. The focus is simple: finding companies with improving momentum, early market attention, and asymmetric upside potential. My watchlist: $VEEE + 400% ~ 450% $SOBR + around 100% $WBUY +70% ~ 80% $CRNX + 50% ~ 60% $ATAI + 40% ~ 50% Not every stock will follow the same path, but the biggest moves often start when fewer people are paying attention. The market rewards preparation, patience, and being early. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
View on StockTwits ↗
meow meowmix@GEEK102Jul 22
$ATER $GRPN $SOUN $ABTC $CRNX You insider piece of cum fget
View on StockTwits ↗
5,500% ROI this quarter@55X_ROI_Q1_2026Jul 22
$SLS $VRTX x $CRNX proxy details: How Buyouts Happen.
View on StockTwits ↗
The Stock Navigator@StockNavigator_Jul 20
Five stocks with market capitalizations under $10 billion are on my watchlist. Not because they've already made the biggest move... But because I believe they still have the potential to create outsized returns over the coming years. This month's focus: 1. $FBRX +129% 2. $CRNX +117% 3. $TRAX +96% 4. $PHOE +78% 5. $ALIT +58% The biggest winners are rarely obvious when they're still small. That's why I spend more time building my watchlist than chasing headlines. Next alert is coming soon. If you're not following with notifications on, you're likely seeing the move after it already happened.
View on StockTwits ↗
The Stock Navigator@StockNavigator_Jul 19
July Trading Recap! Despite a challenging market environment, several names delivered strong moves this month. Performance highlights: $INHD +3000% $GMM +150%~200% $NXTC +around 150% $FBRX +120%~130% $CRNX +around 120% Strong momentum often comes from finding opportunities before they become crowded. The focus is always on identifying trends, understanding catalysts, and managing risk along the way. Not every setup works, but preparation creates opportunities when the market moves. Next alert is coming soon. If you’re not following with notifications on, you’re likely seeing the move after it already happened.
View on StockTwits ↗
Steve Rogers@Steve_TheBull_RogersJul 19
$CRNX Someone knew. Someone traded on inside information They turned $5,442 into $1,571,835 Percentage gain: approximately 28,783% Someone always knows! Uggggh 5k into 1.5M in profit is insane
View on StockTwits ↗
Terry Tyler@TerrytylerJul 18
$GMM $NXTC $CRNX $NVVE $FBRX Those all already run.
View on StockTwits ↗
The Stock Navigator@StockNavigator_Jul 17
July Stock Watchlist: Stocks Worth Watching Momentum has been building in several small and mid-cap names this month. These are the stocks I’m keeping on my radar: $GMM +150%~200% $NXTC +150%~200% $CRNX +115%~120% $NVVE +Approximately 100% $FBRX +100%~110% Strong moves always attract attention, but the key is understanding the catalyst, the trend, and whether the story still has room to develop. Not every runner continues higher. The goal is finding opportunities before the crowd returns. If you want to see the high-conviction stocks I’m watching, my full portfolio, and every trade I make… Head to my profile.
View on StockTwits ↗
Mark bradshaw@livinginmyvandownriverJul 16
$ATAI $CRNX $FBRX $GMM $JZXN PSIL 52 week high today
View on StockTwits ↗
The Stock Navigator@StockNavigator_Jul 16
This could be one of the most interesting setups to watch heading into the second half of 2026. Small and mid-cap names can move quickly when momentum, catalysts, and market attention align. My July watchlist: $ATAI $5.0 → $7.1 +40% $CRNX $38 → ~$84 +120% $FBRX $21 → ~$43 +100% $GMM $2.0 → ~$6 +200% $JZXN $1.3 → ~$2.5 +90% Not every setup will continue higher, but these are the types of names I’m tracking for potential momentum and asymmetric opportunities. The key is patience. Watch the trend. Manage risk. If you want to see the high-conviction stocks I’m watching, my full portfolio, and every trade I make… Head to my profile.
View on StockTwits ↗
WallStWireAds@WallStWireAdsJul 16
$NVCT $TGTX $VRTX $JBIO $CRNX
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.